SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001563665-22-000010
Filing Date
2022-11-14
Accepted
2022-11-14 14:20:22
Documents
16
Period of Report
2022-11-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tmb-20221114x8k.htm   iXBRL 8-K 34559
2 EX-99.1 tmb-20221114xex99d1.htm EX-99.1 21376
3 GRAPHIC tmb-20221114xex99d1002.jpg GRAPHIC 79893
4 GRAPHIC tmb-20221114xex99d1001.jpg GRAPHIC 12671
5 GRAPHIC tmb-20221114xex99d1003.jpg GRAPHIC 111457
  Complete submission text file 0001563665-22-000010.txt   450755

Data Files

Seq Description Document Type Size
6 EX-101.SCH tmb-20221114.xsd EX-101.SCH 3031
7 EX-101.LAB tmb-20221114_lab.xml EX-101.LAB 14083
8 EX-101.PRE tmb-20221114_pre.xml EX-101.PRE 9201
10 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20221114x8k_htm.xml XML 4267
Mailing Address 84 OCTOBER HILL ROAD SUITE 11 HOLLISTON MA 01746
Business Address 84 OCTOBER HILL ROAD SUITE 11 HOLLISTON MA 01746 (774) 233-7300
Biostage, Inc. (Filer) CIK: 0001563665 (see all company filings)

IRS No.: 455210462 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35853 | Film No.: 221383752
SIC: 3841 Surgical & Medical Instruments & Apparatus